Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMAM
1626
DELISTED
Ambrx Biopharma Inc
AMAM
| $29.1M | 0.01% |
2,042,212
+1,273,387
| +166% | +$14.5M |
|
1627
Phinia Inc
PHIN
$2.73B
| $29M | 0.01% |
959,059
-232,951
| -20% | -$6.25M |
|
1628
CALL
monday.com
MNDY
$3.7B
| $29M | 0.01% |
154,600
-7,600
| -5% | -$1.22M |
|
1629
CALL
Global X Uranium ETF
URA
$6.27B
| $29M | 0.01% |
1,048,100
-102,800
| -9% | -$2.82M |
|
1630
AstraZeneca
AZN
$243B
| $28.9M | 0.01% |
214,561
-172,339
| -45% | -$22.4M |
|
1631
Bunge Global
BG
$21.8B
| $28.9M | 0.01% |
285,991
+257,243
| +895% | +$27M |
|
1632
PUT
Wheaton Precious Metals
WPM
$61B
| $28.9M | 0.01% |
585,100
-359,500
| -38% | -$16.3M |
|
|
HBI
1633
DELISTED
Hanesbrands
HBI
| $28.8M | 0.01% |
6,450,962
+4,564,508
| +242% | +$18.6M |
|
|
MRSH
1634
CALL
Marsh
MRSH
$89.6B
| $28.8M | 0.01% |
151,800
+75,800
| +100% | +$14.6M |
|
1635
Bath & Body Works
BBWI
$3.91B
| $28.7M | 0.01% |
665,340
-1,450,973
| -69% | -$49M |
|
1636
Broadridge
BR
$19.5B
| $28.7M | 0.01% |
139,451
+124,886
| +857% | +$23M |
|
1637
Southwest Airlines
LUV
$21.7B
| $28.7M | 0.01% |
992,429
+135,539
| +16% | +$3.53M |
|
1638
SPDR Gold Trust
GLD
$143B
| $28.7M | 0.01% |
149,922
-1,229,626
| -89% | -$225M |
|
1639
PUT
Chewy
CHWY
$9.18B
| $28.7M | 0.01% |
1,212,600
-1,377,700
| -53% | -$27.2M |
|
|
SAVE
1640
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
| $28.6M | 0.01% |
1,745,000
+1,424,900
| +445% | +$20.5M |
|
1641
Pliant Therapeutics
PLRX
$66.3M
| $28.6M | 0.01% |
1,578,514
+58,436
| +4% | +$889K |
|
1642
PUT
TransDigm Group
TDG
$69.5B
| $28.5M | 0.01% |
28,200
-14,900
| -35% | -$13.7M |
|
|
BNY
1643
CALL
Bank of New York Mellon
BNY
$111B
| $28.5M | 0.01% |
547,400
+189,900
| +53% | +$8.75M |
|
1644
CALL
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
| $28.5M | 0.01% |
233,290
+143,640
| +160% | +$11M |
|
1645
Simon Property Group
SPG
$71B
| $28.4M | 0.01% |
199,354
+11,864
| +6% | +$1.43M |
|
1646
CALL
Teradyne
TER
$65.5B
| $28.4M | 0.01% |
262,000
-80,600
| -24% | -$7.65M |
|
1647
EyePoint Inc
EYPT
$1.27B
| $28.4M | 0.01% |
1,227,278
+168,231
| +16% | +$1.88M |
|
1648
State Street SPDR S&P Homebuilders ETF
XHB
$1.59B
| $28.3M | 0.01% |
296,250
+178,781
| +152% | +$14.5M |
|
1649
Avis
CAR
$4.87B
| $28.3M | 0.01% |
159,744
-111,532
| -41% | -$20.3M |
|
1650
Edgewise Therapeutics
EWTX
$4.8B
| $28.3M | 0.01% |
2,585,930
-181,506
| -7% | -$1.27M |
|
Similar funds
Ken Griffin's Q4 2023 Portfolio in Review
As of Q4 2023, Ken Griffin held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $25.4B in Q4 2023, closing 1,625 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Ken Griffin's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Ken Griffin's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Ken Griffin fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Ken Griffin's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Ken Griffin opened 1,585 new positions and closed 1,625 in Q4 2023.
- Ken Griffin's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.